Related Experiment Video
Updated: Jan 7, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Basal Ganglia Calcifications With Acute Behavioral Changes: A Case of Fahr's Syndrome
Bassem Al Hariri1, Areej A Ali2, Areej A Hassan3
1Internal Medicine Department, Hamad Medical Corporation, Doha, QAT.
Abstract:
Fahr's syndrome is a complex neurological disorder characterized by abnormal calcium deposition in the brain, leading to atrophy of the cerebral cortex, white matter, and basal ganglia. This case study examines a 28-year-old male patient to illustrate the remarkable clinical heterogeneity of the condition and its diagnostic challenges. Although rare, Fahr's syndrome can profoundly impact patients, presenting with a wide spectrum of symptoms, including motor deficits, cognitive decline, and diverse neurological manifestations. Current management remains predominantly supportive, aimed at controlling seizures and addressing neuropsychiatric complications. The presentation of this young male patient is particularly unusual, challenging conventional demographic assumptions and underscoring the necessity for individualized patient evaluation. Diagnosis relies heavily on neuroimaging, specifically computed tomography (CT) and contrast-enhanced magnetic resonance imaging (MRI), highlighting the critical role of appropriate imaging techniques given the disease/syndrome's variable presentations. This case not only confirms the extensive clinical variability of Fahr's syndrome but also contributes to the development of more personalized diagnostic and therapeutic approaches.
More Related Videos
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Neural Regulation